#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemophagocytic lymphohistiocytosis Liposarcoma metastatic Primary myelofibrosis Systemic sclerosis pulmonary Congenital absence of bile ducts Chronic lymphocytic leukaemia refractory Bulbospinal muscular atrophy congenital Dupuytren's contracture Diabetes insipidus Synovitis Breast cancer Mastocytosis Canavan disease Undifferentiated sarcoma Arginase deficiency More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Trials in Disease Angiosarcoma non-metastatic – Diagnostics Angelman’s syndrome – Treatment Pleural mesothelioma malignant – Life with Disease Thrombotic thrombocytopenic purpura – Trials in Disease Haemophilia B without inhibitors – Diagnostics Fragile X syndrome Usher’s syndrome Haemophilia A with anti factor VIII – Treatment Hereditary ataxia – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CIRTUVIVINT ILOPROST Lorundrostat Cldn6 Rna-Lpx Levothyroxine Sodium ANERATRIGINE MESILATE ISPAGHULA HUSK ADMILPARANT Retinol Acetate Dactylis Glomerata Rbl035.2 Vafidemstat Ecubectedin Ferric Derisomaltose Celecoxib 68Ga-Dpi-4452 Metolazone Olopatadine Cinchocaine Hydrochloride Crovalimab More therapies…

    Learn about Your Condition

    Diabetic autonomic neuropathy Cerebellar ataxia Synovial sarcoma metastatic Exposure via breast milk Neuropathic arthropathy Reperfusion injury Procedural pain Lymphangiosarcoma Oedema peripheral Cirrhosis alcoholic Fallopian tube cancer stage IV Abortion threatened Hepatorenal syndrome Papulopustular rosacea Metabolic surgery More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fungal infection
    Investigated Drugs:
    • Olorofim
    • Amphotericine B, Liposome
    Belgium France Germany Italy The Netherlands Spain

  • Study on the Effectiveness and Safety of 7 vs. 14 Days of Antibiotic Treatment with Meropenem for Patients with Pseudomonas Aeruginosa Blood Infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Pseudomonas infection
    Investigated Drugs:
    • Cefiderocol
    • Delafloxacin
    • Imipenem Monohydrate
    Spain

  • Study on the Effectiveness of Albaconazole and Fluconazole for Treating Acute Vaginal Yeast Infections in Women

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Vulvovaginal candidiasis
    Investigated Drugs:
    • Albaconazole
    • Itraconazole
    • Fluconazole
    Poland Spain

  • Study on the Effects of MBS2320 for Patients with Idiopathic Pulmonary Fibrosis (IPF)

    Not recruiting

    2 1
    Investigated Diseases:
    • Idiopathic pulmonary fibrosis
    Investigated Drugs:
    • Mbs2320
    France Germany Greece Hungary Italy Spain

  • Study on the Effectiveness and Safety of LYR-210 and Dexamethasone for Treating Chronic Sinusitis in Adults Without Nasal Polyps

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic sinusitis
    Investigated Drugs:
    • Mometasone Furoate
    • Dexamethasone
    Belgium Bulgaria Germany Hungary Poland

  • Study of Cefazolin for Patients on Chronic Hemodialysis with Infections

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Device related infection
    • Haemodialysis
    Investigated Drugs:
    • Cefazolin
    France
Previous Page
1 … 42 43 44 45 46 … 48
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!